Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $21.0250 (-3.73%) ($21.0200 - $21.0250) on Wed. Jan. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.16% (three month average) | RSI | 43 | Latest Price | $21.0250(-3.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -1.6% a day on average for past five trading days. | Weekly Trend | FOLD declines -0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(53%) IWO(49%) XBI(48%) IWM(46%) IWC(44%) | Factors Impacting FOLD price | FOLD will decline at least -1.58% in a week (0% probabilities). VIXM(-29%) VXX(-13%) UUP(-11%) UNG(-6%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.58% (StdDev 3.16%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $15.51(-26.23%) | Resistance Level | $22.97 | 5 Day Moving Average | $22.19(-5.25%) | 10 Day Moving Average | $22.65(-7.17%) | 20 Day Moving Average | $22.97(-8.47%) | To recent high | -15.6% | To recent low | 23.7% | Market Cap | $5.429b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |